Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,532 INR | +0.03% | +0.45% | +21.63% |
Sales 2024 * | 486B 5.83B | Sales 2025 * | 539B 6.47B | Capitalization | 3,674B 44.13B |
---|---|---|---|---|---|
Net income 2024 * | 93.06B 1.12B | Net income 2025 * | 113B 1.35B | EV / Sales 2024 * | 7.36 x |
Net cash position 2024 * | 97.98B 1.18B | Net cash position 2025 * | 161B 1.94B | EV / Sales 2025 * | 6.52 x |
P/E ratio 2024 * |
39.2
x | P/E ratio 2025 * |
32.6
x | Employees | 41,000 |
Yield 2024 * |
0.81% | Yield 2025 * |
0.94% | Free-Float | 45.31% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | +0.03% | ||
1 week | +0.45% | ||
Current month | +1.98% | ||
1 month | +0.60% | ||
3 months | +0.12% | ||
6 months | +28.95% | ||
Current year | +21.63% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 81-12-31 | |
Director of Finance/CFO | - | 17-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 23-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1,531 | -0.32% | 1,341,676 |
24-05-16 | 1,536 | +0.58% | 2,684,392 |
24-05-15 | 1,527 | -1.16% | 1,207,536 |
24-05-14 | 1,545 | +1.32% | 2,206,236 |
24-05-13 | 1,525 | +1.23% | 1,628,326 |
Delayed Quote NSE India S.E., May 18, 2024 at 03:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.63% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B | |
+6.11% | 4.77B |
- Stock Market
- Equities
- SUNPHARMA Stock